What is the Lunai Bioworks Inc. stock price forecast?

Lunai Bioworks Inc. is currently trading at $2.85. View real-time AI analysis on Alpha Lenz.

What is Lunai Bioworks Inc. insider trading activity?

View the latest insider trading data for Lunai Bioworks Inc. on Alpha Lenz.

What is Lunai Bioworks Inc.'s P/E ratio?

Lunai Bioworks Inc.'s P/E ratio is -0.3.

Lunai Bioworks Inc.

NASDAQ · LNAI

$2.85+0.24(+9.00%)Pre-market

Ask about Lunai Bioworks Inc.'s future dividend policy...

Alpha Chat Insight

“Lunai Bioworks Inc. trades at a P/E of -0.3 (undervalued) with strong ROE of 833.8%.”

Ask for details →

Company Overview

Lunai Bioworks Inc., a pre-clinical stage biotechnology company, provides medicine, diagnostics, and biodefense products the United States and the Netherlands. It operates through three segments, RENB, BioSymetrics, and RENC. The company is developing a genetically modified allogeneic dendritic cell therapeutic vaccines, including RENB-DC11 to treat solid tumors primarily for pancreatic tumors; and RENB-DC20 for the treatment of breast cancer. It also develops an artificial intelligence platform technology for early cancer detection and its recurrence that uses a multi-omics approach to search for individual biomarkers that are present even in asymptomatic patients. The company was formerly known as Renovaro Inc. and changed its name to Lunai Bioworks Inc. in August 2025. Lunai Bioworks Inc. is headquartered in Los Angeles, California.

CEOMr. David H. Weinstein

Websitehttps://www.lunaibioworks.com

SectorHealthcare

IndustryBiotechnology

Employees29

Company Statistics

FY 2025

Profile

$46.96MMarket Cap

$0.00Revenue

0.00Shares Out

29Employees

Margins

N/AGross

N/AEBITDA

N/AOperating

N/APre-Tax

N/ANet

Valuation

-0.26P/E

-2.20P/B

N/AEV/Sales

-3.12EV/EBITDA

-5.96P/FCF

Growth (CAGR)

N/ARev 3Yr

N/ARev 5Yr

N/AOp Inc 3Yr

N/AOp Inc 5Yr

N/ANet Inc 3Yr

N/ANet Inc 5Yr

Returns

-2162.69%ROA

833.76%ROE

-2153.87%ROIC

Financial Health

$92.70KCash & Cash Equivalents

$29.49MNet Debt

-138.55%Debt/Equity

N/AInterest Cov

Alpha Chat Insight

“Lunai Bioworks Inc. trades at a P/E of -0.3 (undervalued) with strong ROE of 833.8%.”

Ask for details →

Frequently Asked Questions

Lunai Bioworks Inc. (ticker: LNAI) is a company listed on NASDAQ in the Healthcare sector (Biotechnology). It has approximately 29 employees. Market cap is $47M.

The current price is $2.845 with a P/E ratio of -0.26x and P/B of -2.2x.

ROE is 833.76%.